Community-acquired pneumonia epidemiology and demographics
Community-Acquired Pneumonia Microchapters |
Differentiating Community-acquired pneumonia from other Diseases |
Diagnosis |
Treatment |
Case Studies |
Community-acquired pneumonia epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Community-acquired pneumonia epidemiology and demographics |
FDA on Community-acquired pneumonia epidemiology and demographics |
CDC on Community-acquired pneumonia epidemiology and demographics |
Community-acquired pneumonia epidemiology and demographics in the news |
Blogs on Community-acquired pneumonia epidemiology and demographics |
Directions to Hospitals Treating Community-acquired pneumonia |
Risk calculators and risk factors for Community-acquired pneumonia epidemiology and demographics |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Epidemiology
- Pneumonia is one of the leading cause of death in the world and sixth leading cause in the United States.
- Mortality rate is low in patients treated in the outpatient department and somewhat higher in patients admitted.
- A higher mortality rate is seen in invasive diseases, nursing home patients and severe bacteremia.
- More than 40 % mortality rate is seen in ICU admitted patients.
- An increasing rate of CAP is seen with age. 5.16 to 6.11 cases of pneumonia per 1000 persons is observed in the community for adults. A pronounced seasonal effect on the number of patients presenting to emergency department was also noted. During the winter months, there was up to a 50% increase in the number of cases compared with the summer months.[1]S.pneumonia is the leading cause of pneumonia worldwide inspite of different etiologies worldwide
- Pneumonia and influenza are the eighth and seventh cause of death in the United states and Canada respectively.[2][3]A death rate of more than 60000 persons was recorded in 2005 due to pneumonia in ages more than 15 years. A difference in mortality ratio is observed in different countries like in United States/Canada 7.3 percent, Latin America 13.3 percent, Europe 9.1 percent.[4]
References
- ↑ Marrie, TJ.; Huang, JQ. (2005). "Epidemiology of community-acquired pneumonia in Edmonton, Alberta: an emergency department-based study". Can Respir J. 12 (3): 139–42. PMID 15875065. Unknown parameter
|month=
ignored (help) - ↑ File, TM.; Marrie, TJ. (2010). "Burden of community-acquired pneumonia in North American adults". Postgrad Med. 122 (2): 130–41. doi:10.3810/pgm.2010.03.2130. PMID 20203464. Unknown parameter
|month=
ignored (help) - ↑ Kung, HC.; Hoyert, DL.; Xu, J.; Murphy, SL. (2008). "Deaths: final data for 2005". Natl Vital Stat Rep. 56 (10): 1–120. PMID 18512336. Unknown parameter
|month=
ignored (help) - ↑ Arnold, FW.; Wiemken, TL.; Peyrani, P.; Ramirez, JA.; Brock, GN. (2013). "Mortality differences among hospitalized patients with community-acquired pneumonia in three world regions: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study". Respir Med. 107 (7): 1101–11. doi:10.1016/j.rmed.2013.04.003. PMID 23660396. Unknown parameter
|month=
ignored (help)